Date: 2012-09-19
Type of information: Services contract
Compound: NIH Small Molecule Repository (SMR)
Company: Evotec (Germany) NIH (USA)
Therapeutic area:
Type agreement: services
Action mechanism:
Disease:
Details: Evotec has entered into a multi-year compound management agreement with the National Institutes of Health (NIH), Department of Health and Human Services, for the operation of a Small Molecule Repository. The NIH Small Molecule Repository (SMR) contract will continue to provide services initiated previously under contract N01MH41001 to acquire, store, maintain, and distribute the current library collection, supporting certain NIH-supported screening Centers conducting high-throughput screening (HTS) for probe and drug discovery. As part of continuing efforts to expand and support translational science, this contract resource will now be made available to select outside collaborators (in addition to the NIH screening efforts/programs). Library development efforts will continue to shape, improve, and expand the collection.
This long term contract will be managed through Evotec\'s San Francisco subsidiary.
Financial terms: The contract (funded in its entirety by NIH) covers a period of up to ten years and has a total estimated value of up to € 60 million (approx. USD 75 million).
Latest news:
